期刊名称：JOURNAL OF BUON ISSN： 1107-0625 出版频率： Bi-monthly 出版社： IMPRIMATUR PUBLICATIONS, 30 DEM POLIORKETES ST, ATHENS, GREECE, 136 76 期刊网址： http://www.jbuon.com/web/index.php 影响因子： 2.533 主题范畴： ONCOLOGY 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Journal information   JBUON is an independent Open Access Journal, published by Imprimatur Publications, in Athens, Greece, and  appears exclusively on the internet. It is covered/indexed in PUBMED/MEDLINE, PUBMED Central, Science Citation Index Expanded (SCIE), SciSearch, Web of Science, Global Health, Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica, Index Copernicus, and SCOPUS. JBUON aims at the rapid diffusion of scientific knowledge in Oncology. Its character is multidisciplinary,therefore all aspects of oncologic activities are welcome including clinical research (medical oncology,radiation oncology,surgical oncology,nursing oncology,psychooncology,supportive care),as well as clinically-oriented basic and laboratory research,cancer epidemiology and social and ethical aspects of cancer. Experts of all these disciplines are included in the Editorial Board. With a rapidly increasing body of new discoveries in clinical therapeutics,the molecular mechanisms that contribute to carcinogenesis,advancements in accurate and early diagnosis etc, JBUON offers a free forum for clinicians and basic researchers to make known promptly their achievements around the world. With this aim JBUON accepts a broad spectrum of articles such as editorials,original articles,reviews,special articles,short communications,commentaries,letters to the editor and correspondence among authors and readers. JBUON will keep the characteristics of its former paper print edition and will appear as a quartely e-published journal with continuous volume,issue and page numbers. For detailed article submission visit "Manuscript submission".   Indexed in: PUBMED/MEDLINE, PUBMED Central, Science Citation Index Expanded (SCIE), SciSearch, Web of Science, Global Health, Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica, Index Copernicus, SCOPUS and DOAJ     Instructions to Authors Manuscript submission Manuscripts should be submitted with a letter stating that the report is not submitted for publication elsewhere and that all authors have agreed to its submission. Studies should be carried out in accordance with the relevant local, national, and international guidelines. All papers will be sent out for external peer review. Authors will be notified of acceptance, need for revision or rejection within 3 weeks of submission. Upon acceptance of the paper the authors will be asked to transfer the copyright to the Publisher ( publisher@jbuon.com This email address is being protected from spambots. You need JavaScript enabled to view it. ). Contributors of accepted articles are provided with proofs and corrections have to be returned within one week from receipt of the proof by E-mail ( editorial_office@jbuon.com This email address is being protected from spambots. You need JavaScript enabled to view it. ). If this deadline is not met, the publication of the article will be postponed and in extreme cases the article will be rejected. A cover letter to publish testifying authorship responsibility and financial disclosures or conflicts of interest is required for the reviewing procedure and should be included in each manuscript submission. JBUON publishes material in the form of editorials, reviews, original articles, short communications, special articles, commentaries, letters to the editor, and correspondence. Position articles and medical hypotheses are also welcome the length of which will be agreed between editor and author. Manuscripts should be written in English. Authors whose native language is not English are strongly advised to have their manuscripts checked by an English-speaking colleague prior to submission. Manuscripts should be typewritten (double-spaced) and must be submitted by E-mail directly to the Editorial Office ( editorial_office@jbuon.com This email address is being protected from spambots. You need JavaScript enabled to view it. ). Editorials, reviews: Editorials and reviews may be solicited by the editor. Unsolicited reviews will also be considered. The length of the editorial will be agreed upon between editor and author while reviews summarizing state-of-the art of a particular field should not exceed 3000 words. Original articles: Manuscripts are accepted for publication with the understanding that they represent new contributions to the scientific literature and have not been published or submitted for publication elsewhere. They should generally be no longer than 3000 words and must be prepared according to specific instructions (see below). Short communications: Short communications generally summarize clinical trials, important clinical observations, and significant preliminary experimental data. Studies with negative results are also accepted when their knowledge is of interest to the scientific community. Special articles: Special articles review a specific field providing at the same time original or partially known data. They should not exceed 2000 words and 20 references. Commentaries: Commentaries usually deal with reports of scientific meetings which are of broad interest to the scientific community. They must be no longer than 2000 words. Letters to the Editor: Letters are welcome and will be published if appropriate. They usually deal with clinicolaboratory observations. They should be titled, not exceed 500 words, and have a maximum of 5 references. Up to 1 table or figure may be submitted, but will be published at the discretion of the editor. Correspondence: Correspondence includes comments on published papers. It should be no longer than 500 words and contain up to 10 references.  Instructions for original articles Original articles in general should be organized in the following order: Title page: The first page should contain the following information: 1) Title of the paper, 2) Authors’ names; 3) Corresponding affiliation(s) and name of Institution(s) in which the work was done; 4) Acknowledgements for research support; 5) Name, title(s), mail address, and e-mail address, telephone and fax numbers of the author to whom correspondence regarding the manuscript should be directed. Summary: The second page should contain a summary of no more than 250 words and a maximum of 6 key words (in alphabetical order, suitable for indexing). Summary must be organized and formatted according to the following headings: Purpose, Methods, Results, Conclusions. Main text: The text should be organized and formatted under the following headings: Introduction, Methods, Results, Discussion. Tables and figures: Tables and figures must be listed in the order they are cited in the text using Arabic numerals and should be placed each on a separate page at the end of your file. Ensure that each table and figure is cited in the text. A short descriptive title should appear above each table and any footnotes, suitably identified, below. Provide headings for all columns and indicate units of measurement, where applicable. Always separate the individual columns using tabs, not spaces. Type figure legends on a separate page and identify in the legend any lettering used in the figure. Photomicrographs should have the magnification and details of staining techniques. All figures should be submitted in electronic format(s) and meet the specifications described below. References: The accuracy of references is the responsibility of the authors. References should be entered consecutively by Arabic numerals in square brackets in the text. The reference list should be written in numerical order on a separate page. Follow the standard form of Index Medicus. References to Abstracts and Letters to the Editor must be identified as such. Citation of papers in preparation or submitted for publication, unpublished observations and personal communications should not be included in the reference list. They can, however, appear in the text (e.g. J. Smith, personal communication). For periodicals provide authors’ names and initials, full title of the paper, journal title abbreviated using Index Medicus abbreviations, year of publication, volume number, first and last page. Note: list all authors when 6 or less; when 7 or more list only the first 3 and add “et al.”, e.g.: Bauduceau O, Bollet MA, Pons P et al. The use of computed tomography in radiotherapy treatment planning for breast cancer. How does conventional radiotherapy planning compare with virtual? JBUON 2008; 13:245-251.  For books provide author(s)’ name and initials, title of the pertinent chapter or section title, name(s) of editor(s), title of the book with number of edition if no first edition, location and name of publisher, year, or section title and page numbers, e.g.: Bommer GT, Fearon ER. Molecular abnormalities in colon and rectal cancer. In: Mendelsohm J, Howley PM, Israel MA, Gray JW, Thompson CB (Eds): The molecular basis of cancer (3rd Edn). Saunders, Philadelphia, 2008, pp 409-421. Electronic manuscript Text: Electronic manuscript formats should be readable by commonly available word processing software (e.g. rich text format [.rtf], Microsoft Word document [.doc], Open Office document [.odt]). Do not submit manuscripts saved in portable document format (.pdf) as they cannot be easily edited. Any words or phrases in the text that you wish to emphasize should be indicated throughout the paper in italic and not in bold. Please delete any annotations or comments from the final text file. Figures: If your article includes figures, please note that electronic submission involves at least two computer files depending on the number of the figures you use: 1) one text file containing the manuscript and the figures at the end of the text, as described above, and 2) each figure separately in their original digital format no matter what that is (.jpg, .pdf, .eps, .tif, .doc, .xls etc.). Color illustrations Color illustrations are free of charge. Permissions Written permission to reproduce borrowed material (illustrations, tables and photographs) must be obtained. Authors must ensure that appropriate permission has been obtained for the publication of identifiable clinical photographs. Borrowed and previously published material should be acknowledged in the captions in this style: “Reproduced by kind permission of... (publishers) ... from ... (reference)”. It is the responsibility of the author to obtain all such permissions from the original publishers and authors, and to submit them with the manuscript. Proofs After manuscript correction by the Editorial Office authors will receive their paper via e-mail in doc format for proofreading. Proofs should be returned to the Editorial Office via e-mail within one week. The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor. After publication, further changes can only be made in the form of an Erratum. Offprints The corresponding author will receive electronically a reprint in PDF format via e-mail for his/her own files and will be responsible for the distribution of the PDF reprint among his/her co-authors. Authorship responsibility The journal’s definition of what qualifies as authorship is based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, established by the International Committee of Medical Journal Editors (ICMJE). Authors are those who have contributed to the conception and design of the article, the acquisition of data, or the analysis and interpretation of data, as well as the writing of the article or the revision of its content; and have read and approved the final version of the article before submission. Ethics Papers that contain results of human and/or animal studies will be accepted for publication only if it is made clear that a high standard of ethics was applied in carrying out the investigations. When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Thus, papers reporting clinical studies should, where appropriate, contain a statement that they have been carried out with the ethical committee’s approval. When reporting experiments on animals, authors should indicate whether the institutional and national guidelines for the care and use of laboratory animals were followed. Papers disregarding the welfare of experimental animals will be rejected. Authors may find the UKCCCR “Guidelines for the Welfare of Animals in Experimental Neoplasia” helpful in this regard. JBUONdoes not accept work that is funded in any part by tobacco industry sources. Conflicts of interest Authors are required to disclose all relevant financial support and potential conflicts of interest in their cover letter, within the manuscript, and on the copyright transfer agreement. If there are no financial disclosures from any author, this should be stated as well. In addition, authors have an ethical responsibility to ensure all research discussed in their work is credible and data are accurate prior to publication. Authors must also clearly identify in the manuscript any discussion of investigational or “off-label” use of drugs or medical devices. The authors will be required to submit such disclosures when submitting their manuscript in the cover letter. Acknowledgements All other persons who contributed to the work should be listed in “Acknowledgements”. These include people who provided purely technical help, writing assistance, or general support. All financial support should be clearly acknowledged as well as any detail regarding the role of the funding organization in the creation of the manuscript. Corresponding author’s responsibilities The corresponding author is the point of contact with the Editorial Office and Publisher. He or she is responsible for: Collecting signed copyright transfer agreements and CME disclosure forms (if the manuscript is associated with a CME quiz) from all authors and submitting these to the Editorial Office with the manuscript. Sharing the reviewers’ comments with the other authors and ensuring the requested revisions are made or clearly disputed before resubmitting the manuscript. Page proofs. The Editorial Office will e-mail page proofs to the corresponding author. It is up to the corresponding author to share these proofs with the other authors. The corresponding author is responsible for incorporating all the corrections made by the authors and returning the proofs to the Editorial Office within 1 week. Publication fees J BUON is an independent open access journal providing free access to full text of all published articles to all online interested readers around the world. To cover the costs of the publication procedures authors pay a fee of 370 euro per article, irrespective of number of pages, number of tables, figures and color illustrations. This fee is equally distributed among all authors. Advertisements For advertisement information, please contact the Publisher ( publisher@jbuon.com This email address is being protected from spambots. You need JavaScript enabled to view it. ). Instructions to Authors 1107-0625ue.pdf Editorial Board Editor-in-Chief A.E. ATHANASIOU, Athens, Greece Associate Editors S. Radulović, Beograd, Serbia Lj. Vučković-Dekić, Beograd, Serbia S. Karanov, Sofia, Bulgaria M. Kinay, Izmir, Turkey D. Trafalis, Athens, Greece Editorial Board M. Alakavuklar, Izmir, Turkey I. Alexandru, Cluj-Napoca, Romania K. Altundag, Ankara, Turkey G. Androutsos, Athens, Greece R. Anghel, Bucharest, Romania J.P. Armand, Toulouse, France J.O. Armitage, Omaha, USA N. Arsenijević, Kragujevac, Serbia R.C. Bast Jr, Houston, USA R.H. Begent, London, UK A. Bikfalvi, Talence, France G. Bogdanović, Sremska Kamenica, Serbia P. Bosze, Budapest, Hungary N. Bountouroglou, Piraeus, Greece M. Branković-Magić, Beograd, Serbia S. Brkić, Novi Sad, Serbia P.A. Bunn Jr, Denver, USA K. Christov, Chicago, USA T. Ciuleanu, Cluj-Napoca, Romania M. D’Incalci, Milano, Italia M. Dediu, Bucharest, Romania V.Diehl, Koln, Germany C. Dittrich, Vienna, Austria T. Dragovich, Tucson, USA R. Dzodic, Beograd, Serbia A. Eniu, Cluj-Napoca, Romania S. Filipović, Nis, Serbia E.J. Freirech, Houston, USA D. Gavrilovic, Beograd, Serbia L. Gocheva, Sofia, Bulgaria M. Greco, Milano, Italia A. Grivas, Piraeus, Greece J.L. Lopez Guerra, Seville, Spain A. Guler, Izmir, Turkey H. Hansen, Copenhagen, Denmark  A. Haydaroglu, Izmir, Turkey J.C. Holland, New York, USA J.C. Horiot, Dijon, France R. Igić, Chicago, USA A. Irimic, Cluj-Napoca, Romania G. Karikas, Athens, Greece J. Katsilieris, Athens, Greece S.B. Kaye, Glasgow, UK N. Kentepozidis, Athens, Greece B. Klein, Kfar-Saba, Israel A. Kortsaris, Alexandroupolis, Greece A. Kulakowski, Warsaw, Poland S. Linardopoulos, London, UK I. Lubinski, Szczecin, Poland Z. Magić, Beograd, Serbia V. Malamou-Mitsi, Ioannina, Greece M. Malumbres, Madrid, Spain A. Mandić, Sremska Kamenica, Serbia G. Marjanović, Nis, Serbia J. Meletis, Athens, Greece L. Miron, Iasi, Romania A. Molassiotis, Manchester, UK A. Nencioni, Genova, Italy Z. Nesković-Konstantinović, Beograd, Serbia M. Ozguroglu, Istanbul, Turkey R.Z. Ozols, Philadelphia, USA G. Panagos, Athens, Greece B. Perin, Topolsica, Slovenia H.M. Pinedo, Amsterdam, The Netherlands A.D. Purushotham, Cambridge, UK D. Radosavljević, Beograd, Serbia D. Raghavan, Los Angeles, USA G. Rigatos, Athens, Greece S. Ruacan, Ankara, Turkey P. Rusu, Cluj-Napoca, Romania M. Sakizli, Izmir, Turkey A. Sallaku, Tirana, Albania M.A.N Sendur, Ankara, Turkey Xiying Shang, San Diego, USA J.F. Smyth, Edinburgh, UK D. Spandidos, Athens, Greece I. Tannock, Toronto, Canada L. Teppo, Helsinki, Finland A. Thanos, Athens, Greece E. Tsiambas, Athens, Greece V. Tzekova, Sofia, Bulgaria Z. Valerianova, Sofia, Bulgaria A.T. Van Oosterom, Leuven, Belgium P. Vassilopoulos, Athens, Greece J.B. Vermorken, Edegem, Belgium P.A. Voûte, Amsterdam, The Netherlands E. Wagner, Munich, Germany C. Wang, Houston, USA D. Yannoukakos, Athens, Greece G. Yuceturk, Izmir, Turkey   English Editor: Diana Goe-Babasika Editorial Office:  editorial_office@jbuon.com This email address is being protected from spambots. You need JavaScript enabled to view it.